X

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Human Tolerance and Kinetics of LY03003 By Single Intramuscular Injection

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rotigotine (Primary)
Indications Parkinson's disease
Focus Pharmacokinetics
Sponsors Luye Pharma Group

Most Recent Events

29 Aug 2019 According to a Luye Pharma Group media release, a clinical trial application for this trial was filed.
18 Mar 2019 New trial record
12 Mar 2019 According to a Luye Pharma Group media release, the company announced that they have commenced this study in Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com